These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29626009)

  • 1. The Nurr1 Ligand,1,1-bis(3'-Indolyl)-1-(
    Hammond SL; Popichak KA; Li X; Hunt LG; Richman EH; Damale PU; Chong EKP; Backos DS; Safe S; Tjalkens RB
    J Pharmacol Exp Ther; 2018 Jun; 365(3):636-651. PubMed ID: 29626009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.
    De Miranda BR; Popichak KA; Hammond SL; Miller JA; Safe S; Tjalkens RB
    Toxicol Sci; 2015 Feb; 143(2):360-73. PubMed ID: 25406165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's disease.
    De Miranda BR; Miller JA; Hansen RJ; Lunghofer PJ; Safe S; Gustafson DL; Colagiovanni D; Tjalkens RB
    J Pharmacol Exp Ther; 2013 Apr; 345(1):125-38. PubMed ID: 23318470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro.
    Hammond SL; Safe S; Tjalkens RB
    Neurosci Lett; 2015 Oct; 607():83-89. PubMed ID: 26383113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB.
    De Miranda BR; Popichak KA; Hammond SL; Jorgensen BA; Phillips AT; Safe S; Tjalkens RB
    Mol Pharmacol; 2015 Jun; 87(6):1021-34. PubMed ID: 25858541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
    Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel diindolylmethane analog, 1,1-bis(3'-indolyl)-1-(p-chlorophenyl) methane, inhibits the tumor necrosis factor-induced inflammatory response in primary murine synovial fibroblasts through a Nurr1-dependent mechanism.
    Afzali MF; Popichak KA; Burton LH; Klochak AL; Wilson WJ; Safe S; Tjalkens RB; Legare ME
    Mol Immunol; 2018 Sep; 101():46-54. PubMed ID: 29870816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensatory Expression of Nur77 and Nurr1 Regulates NF-
    Popichak KA; Hammond SL; Moreno JA; Afzali MF; Backos DS; Slayden RD; Safe S; Tjalkens RB
    Mol Pharmacol; 2018 Oct; 94(4):1174-1186. PubMed ID: 30111648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of Nanotization-Mediated Improvement in the Efficacy of Caffeine Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism.
    Singhal NK; Agarwal S; Bhatnagar P; Tiwari MN; Tiwari SK; Srivastava G; Kumar P; Brashket S; Patel DK; Chaturvedi RK; Singh MP; Gupta KC
    J Biomed Nanotechnol; 2015 Dec; 11(12):2211-22. PubMed ID: 26510314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
    Ghosh A; Roy A; Matras J; Brahmachari S; Gendelman HE; Pahan K
    J Neurosci; 2009 Oct; 29(43):13543-56. PubMed ID: 19864567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of a herbal extract combination of Bupleurum falcatum, Paeonia suffruticosa, and Angelica dahurica against MPTP-induced neurotoxicity via regulation of nuclear receptor-related 1 protein.
    Sim Y; Park G; Eo H; Huh E; Gu PS; Hong SP; Pak YK; Oh MS
    Neuroscience; 2017 Jan; 340():166-175. PubMed ID: 27771535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
    J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway.
    Kambey PA; Chengcheng M; Xiaoxiao G; Abdulrahman AA; Kanwore K; Nadeem I; Jiao W; Gao D
    Metab Brain Dis; 2021 Apr; 36(4):609-625. PubMed ID: 33507465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
    Gottschalk CG; Jana M; Roy A; Patel DR; Pahan K
    J Neurosci; 2021 Mar; 41(10):2287-2300. PubMed ID: 33514677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nurr1 ligand C-DIM12 attenuates brain inflammation and improves functional recovery after intracerebral hemorrhage in mice.
    Kinoshita K; Yoshimizu A; Ichihara Y; Ushida K; Kotani S; Kurauchi Y; Seki T; Katsuki H
    Sci Rep; 2022 Jun; 12(1):11009. PubMed ID: 35773404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease.
    Jarras H; Bourque M; Poirier AA; Morissette M; Coulombe K; Di Paolo T; Soulet D
    J Neuroendocrinol; 2020 Jan; 32(1):e12782. PubMed ID: 31430407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
    Burks S; Raymick J; Robinson B; Hanig J; Sarkar S
    Neurosci Lett; 2019 Jun; 703():86-95. PubMed ID: 30890473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease.
    Zhang Z; Li X; Xie WJ; Tuo H; Hintermann S; Jankovic J; Le W
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):768-73. PubMed ID: 22483304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.